• Quality of life - Health - Food

Handicap Neuromusculaire : Physiopathologie, Biotechnologies et Pharmacologies Appliquées (END-ICAP)

Research unit

Description

The research carried out END-ICAP focuses on the study of physiopathological processes of neuromuscular diseases and their effects on movement, respiratory and sexual activity. Thanks to its many industrial partners (Pelvipharm, Synthena ...) and its place among many international collaboration networks, most of their research reaches clinical trials.

Contacts

  • Mr Luis GARCIA

http://www.end-icap.uvsq.fr/

Innovation themes

Map and access

2, avenue de la source de la Bièvre
UFR Simon Veil
78180 MONTIGNY LE BRETONNEUX

Our research areas

Expertises

- genetics and genetic diseases
- myology
- nephrology
- urology
- pneumology
- physical therapy
- disabilities

Applications sectors

  • Biotechnology

Total number of employees

Total number of employees : 50

Equipment(s) open to collaboration

L3 laboratory

Keywords

Our results

Projects examples

- project HandiMedEx

Industrial and scientific relations

Scientific collaborations

LIMSI, CesamS, LBPA, PALM, IPS2, iSSB, Structure de Reconnaissance des Biomolécules, HITH, CMH, LETG, LAMBE, England, USA

Private collaborations

- collaboration with several companies

Ecosystem

Establishments of affiliation

Edit request

You enter the « edit request » mode. After sending your modifications, they will first be validated by the Plug in labs University Paris Saclay team, before appearing on the platform.

Thematics

Current thematics

  • Quality of life - Health - Food
    • Therapeutic technologies (drugs, genetics, biomarkers, biomolecules, etc.)
Title

Current content

Handicap Neuromusculaire : Physiopathologie, Biotechnologies et Pharmacologies Appliquées (END-ICAP)
Type

Current content

Research unit
Workforce

Current content

Effectif total : 50
Nombre de chercheurs :
Nombre de doctorants :
Description

Current content

The research carried out END-ICAP focuses on the study of physiopathological processes of neuromuscular diseases and their effects on movement, respiratory and sexual activity. Thanks to its many industrial partners (Pelvipharm, Synthena ...) and its place among many international collaboration networks, most of their research reaches clinical trials.
Contact informations
Contact

Current content

Contact name Email phone number
Luis-GARCIA luis.garcia@uvsq.fr
URL

Current content

http://www.end-icap.uvsq.fr/

Address

Current content

2, avenue de la source de la Bièvre
UFR Simon Veil
78180 MONTIGNY LE BRETONNEUX
Lab of attachment

Current content

Keywords

Current content

pharmacology, biotherapy, disability, neuromuscular
Our search domains
Expertises

Current content

- genetics and genetic diseases
- myology
- nephrology
- urology
- pneumology
- physical therapy
- disabilities
Applications sectors

Current content

Biotechnology

Equipments

Current content

L3 laboratory
Our results
Valuation offer

Current content

Offers types

Current content

Examples of work

Current content

- project HandiMedEx
Publications

Current content

Scientific collaborations

Current content

LIMSI, CesamS, LBPA, PALM, IPS2, iSSB, Structure de Reconnaissance des Biomolécules, HITH, CMH, LETG, LAMBE, England, USA
Private collaborations

Current content

- collaboration with several companies
Ecosystem
Affiliated institutions

Current content

Institutional groups

Current content

Research departments

Current content

PIA links

Current content

Competitivness clusters

Current content

Carnot Institutes

Current content

Doctoral school

Current content

Personal informations
Back to top